<pad>key clinical messagea 42-year - old female with h/o cholangiocarcinoma dx in dx/o had recently been admitted to hospital due to severe cholangitis. <n> she was treated with rituximab, cyclosporine a and ceftazidime. <n> her condition improved and she was discharged. <n> we suggest that rituximab and ceftazidime should be used cautiously in patients with severe cholangitis.</s>